Despite increasing evidence that uveitis is common and consequential in survivors of Ebola
virus disease (EVD), the host-pathogen determinants of the clinical phenotype are …

Ebola virus disease (EVD) and emerging infectious disease threats continue to threaten life,
prosperity and global health security. To properly counteract EVD, an improved …

Ocular complications of Ebola virus disease are well-documented and long-term sequelae
in survivors are common and lead to considerable morbidity. However, little is currently …

Purpose: Success of Ebola virus (EBOV) as a human pathogen relates at the molecular level
primarily to blockade the host cell type I interferon (IFN) antiviral response. Most individuals …

Zaïre ebolavirus (EBOV) causes Ebola virus disease (EVD), a devastating viral hemorrhagic
fever in humans. Nonhuman primate (NHP) models of EVD traditionally use intramuscular …

Background Ebola virus disease (EVD) survivors are at risk for uveitis during
convalescence. Vision loss has been observed following uveitis due to cataracts. Since …

In the wake of the international Ebola virus disease (EVD) outbreak from 2014 to 2016,
thousands of EVD survivors are at-risk of ophthalmic manifestations, as well as systemic …

Background Ebola virus disease (EVD) survivors experience ocular sequelae including
retinal lesions, cataracts, and vision loss. While monoclonal antibodies targeting the Ebola …

Ebola virus (EBOV) persistence in asymptomatic humans and Ebola virus disease (EVD)
sequelae have emerged as significant public health concerns since the 2013–2016 EVD …

In this issue of the journal, Shantha et al. report a series of cataract surgeries on survivors of
Ebola virus (EBOV) infection. EBOV, originally identified as a new pathogen in 1976 during …